Megan Melody, MD, MS¹, Narendranath Epperla, MD, MS², Geoffrey P. Shouse, PhD, DO³, Jason T. Romancik, MD⁴, Tamara K. Moyo, MD^5*, Vaishalee P Kenkre, MD⁶, Thomas Ollila, MD⁷, Lindsey Fitzgerald, MD⁸, Brian Hess, MD⁹, Kevin A. David, MD^10*, Kaitlin Annunzio, DO¹¹, Megan Herr, PhD¹², Rahul S. Bhansali, MD¹³, Elyse I Harris, MD^14*, James A Davis, PharmD^15*, Oluwatobi Odetola, MD¹⁶, Adam Yuh Lin, MD, PhD¹⁷, Jonathan Moreira, MD¹⁷, Shuo Ma, MD, PhD¹⁸, Jane N. Winter, MD^19*, Deborah M. Stephens, DO⁸, Alexey Danilov, MD³, Nirav N. Shah, MD²⁰, Ishan Roy, MD, PhD²¹, Stefan K. Barta, MD²², Matthew J Cortese, MD, MPH¹², Pallawi Torka¹², Jonathon B. Cohen, MD, MS²³, Leo I. Gordon, MD²⁴ and Reem Karmali, MD, MSc²⁵

¹Feinberg School of Medicine, Northwestern University, Chicago, IL
²The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH
³City of Hope Comprehensive Cancer Center, Duarte, CA
⁴Department of Hematology and Medical Oncology, Winship Cancer Institute at Emory University, Atlanta, GA
⁵Atrium Health / Levine Cancer Institute, Charlotte, NC
⁶Department of Medicine Division of Hematology, Medical Oncology and Palliative Care, University of Wisconsin–Madison, Madison, WI
⁷Brown University, Providence, RI
⁸Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
⁹Medical University of South Carolina, Charleston, SC
¹⁰Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ
¹¹The James Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH
¹²Roswell Park Comprehensive Cancer Center, Buffalo, NY
¹³Abramson Cancer Center, Hospital of the University of Pennsylvania, Philadelphia, PA
¹⁴Carbone Cancer Center, University of Wisconsin–Madison, Madison, WI
¹⁵Department of Hematology-Oncology, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC
¹⁶Division of Hematology/Oncology, Northwestern University Feinberg School of Medicine, Maywood, IL
¹⁷Robert H Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL
¹⁸Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL
¹⁹Division of Hematology/Oncology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL
²⁰Medical College of Wisconsin, Milwaukee, WI
²¹Shirley Ryan Ability Lab, Chicago, IL
²²Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA
²³Winship Cancer Institute, Emory University, Atlanta, GA
²⁴Department of Medicine, Division of Hematology/Oncology and the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Northwestern University Feinberg School of Medicine, Chicago, IL
²⁵Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL

Daniel J. Landsburg, MD¹, Jennifer JD Morrissette, PhD^2*, Sunita D. Nasta, MD³, Stefan K. Barta, MD³, Stephen J Schuster, MD⁴, Jakub Svoboda, MD³, Elise A. Chong, MD³ and Adam Bagg, MD²

¹Abramson Cancer Center, University of Pennsylvania, Lymphoma Program, Philadelphia, PA
²Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA
³Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
⁴Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA

Christine Hanoun, MD^1*, Martijn Heymans^2*, Sanne Wiegers^3*, Annelies Bes^4*, Ulrich Duehrsen, MD^5*, Andreas Huettmann, MD^1*, Lars Kurch, MD^6*, Sally F Barrington, MD^7*, George Mikhaeel, MD^8*, Pieternella Lugtenburg, MD, PhD⁹, Luca Ceriani, MD^10*, Emanuele Zucca, MD^11,12, Tamas Gyorke, MD^13*, Sandor Czibor^14*, Gerben Zwezerijnen^15*, Ronald Boellaard^16*, Josée M. Zijlstra, MD, PhD¹⁷ and Corinne Eertink, Msc^18*

¹Hematology, Uniklinikum Essen, Essen, Germany
²Amsterdam UMC, Location Vumc, Amsterdam, NLD
³Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Hematology, Cancer Ce, Amsterdam, NLD
⁴Hematology, Amsterdam UMC, Amsterdam, Netherlands
⁵Universitatsklinikum Essen, Essen, DEU
⁶University Hospital Leipzig, Leipzig, DEU
⁷School of Biomedical Engineering and Imaging Sciences, King's College London and Guy's and St Thomas' PET Centre, London, United Kingdom
⁸Guy's Cancer Centre, Guy's & St Thomas' NHS Trust and King's College University, London, United Kingdom
⁹Erasmus MC Univ. Med. Ctr. Rotterdam, Rotterdam, NLD
¹⁰Imaging Institute of Southern Switzerland (IIMSI), Lugano, Switzerland
¹¹IOSI-Oncology Inst. of Southern Switzerland, Lodrino, Switzerland
¹²Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
¹³Semmelweis Egyetem, Budapest, Hungary
¹⁴Department of Nuclear Medicine, Medical Imaging Centre, Semmelweis University, B, Budapest, HUN
¹⁵Cancer Center Amsterdam, Amsterdam UMC Radiology and Nuclear Medicine, Amsterdam, Netherlands
¹⁶Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Radiology and Nuclear, Amsterdam, Netherlands
¹⁷Cancer Center Amsterdam, Imaging, Amsterdam, Netherlands
¹⁸Cancer Center Amsterdam, Amsterdam UMC, Amsterdam, Netherlands

Takahiro Nakashima, MD^1*, Tomotaka Suzuki^1*, Gakuto Ogawa^2*, Kazuyuki Shimada³, Tsutomu Kobayashi^4*, Dai Maruyama⁵, Wataru Munakata^6*, Ken Ohmachi, MD^7*, Tomohiro Kinoshita⁸, Kiyoshi Ando^7* and Hirokazu Nagai, MD, PhD⁹

¹Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
²JCOG Data Center, National Cancer Center Hospital, Tokyo, Japan
³Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan
⁴Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan
⁵Department of Hematology Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
⁶Department of Hematology, National Cancer Center Hospital, Tokyo, Japan
⁷Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan
⁸Department of Hematology and Cell Therapy, Aichi Cancer Center Hospital, Nagoya, Japan
⁹Department of Hematology and Oncology Research, National Hospital Organization, Nagoya Medical Center, Nagoya, Japan

Candice Jamois, PharmD^1*, David C. Turner, PhD^2*, Leonid Gibiansky, PhD^3*, Feifei Li, MS^2*, Nicolas Frey, PharmD^1*, Jean-Francois Menuet, ScM^4*, Leonardo Roque Pereira, MSc^5*, Linda Lundberg, PhD^1*, Elena Guerini, PgD^1*, David John Carlile, PhD BSc^5*, James Relf, MD^5*, Michael C. Wei, MD, PhD², Antonia Kwan, MBBS, PhD^2* and Susan Grange, PhD^1*

¹Roche Innovation Center Basel, Basel, Switzerland
²Genentech, Inc., South San Francisco, CA
³QuantPharm LLC, North Potomac, MD
⁴Syneos Health France, Montrouge, France
⁵Roche Innovation Center Welwyn, Welwyn, United Kingdom

Imad Faghmous^1,2* and Antonio Nicolae, MS^3*

¹Inovia Bio, London, United Kingdom
²University of Bradford, London, United Kingdom
³Inovia Bio, London, GBR

Xiping Liang^*, Renzhi Hu^*, Chaoyu Wang^*, Qiying Li^*, Tao Yang^*, Bingling Guo^*, Chunyan Xiao^* and Yao Liu, PhD, MD

Department of Hematology-Oncology, Chongqing University Cancer Hospital, Chongqing, China

Li Wang, MD^1,2*, Ying Fang^1*, Muchen Zhang^1*, Jie Xiong, PhD^1*, Pengpeng Xu^1*, Shu Chen^1* and Weili Zhao^1,2

¹Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Rui Jin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
²Chinese‐French Research Center in Living Science and Genomics, Laboratory of Molecular Pathology, Shanghai, China

Rui Liu^1*, Fan Yang^1*, Xiaoyan Ke^1,2* and Kai HU^3*

¹Department of Lymphoma and Myeloma Research Center, Beijing Gobroad Boren Hospital, Beijing, China
²Peking University Third Hospital, Beijing, China
³Department of Lymphoma and Myeloma Research Center, Beijing Gobroad Boren Hospital, Beijing, China

Yuhong Ren, MD^1*, Jingli Zhuang, MD.^2*, Ling Yuan, MD.^2*, Lili Ji, MD, PhD^3*, Yang Ke^3* and Peng Liu, MD⁴

¹Zhongshan Hospital Affiliated to Fudan University, Shanghai, Shanghai, China
²Hematology, Zhongshan Hospital Affiliated to Fudan University, Shanghai, China
³Zhongshan Hospital Affiliated to Fudan University, Shanghai, China
⁴Department of Hematology, Zhongshan Hospital, Fudan University, Shanghai, China

Myrna Candelaria, MD¹, Luis Mario Villela Martinez, MD, MSc^2*, Brady E Beltran, MD^3*, Ana Florencia Ramirez, MD^4*, Marialejandra Torres Viera, MD^5*, Carolina Oliver, MD⁶, Henry Idrobo Quintero^7*, Fernando perez-Jacobo, MD^8*, Guilherme Fleury Perini, MD⁹, Camila Peña, MD¹⁰, Laura Korin, MD^11*, Denisse Castro, MD¹², Victoria Irigoín, MD^13*, Sally Rose Paredes, MD^14*, Jose A Hernandez-Hernandez, PhD^15*, Perla R. Colunga-Pedraza, MD¹⁶, David Gomez-Almaguer, MD¹⁷, Guillermo Ruiz-Argüelles, MD^18*, Melani Otañez^19*, Jorge J. Castillo, MD²⁰ and Luis Enrique Malpica Castillo, MD²¹

¹Clinical Research, Instituto Nacional de Cancerologia, Mexico city, Mexico
²Centro Medico Dr. Ignacio Chavez, Hermosillo, Sonora, MEX
³Servicio Oncología Médica, Hospital Edgardo Rebagliati, Lima, Peru
⁴Instituto Nacional de Cancerologia, MExico city, Mexico
⁵Unidad Linfomas, Instituto Hematología y Oncología Universidad Central Venezuela, Caracas, Venezuela (Bolivarian Republic of)
⁶British Hospital, Montevideo, Uruguay
⁷Asociación Colombiana de Hematología y Oncología (ACHO), Bogotá, Colombia
⁸Hospital Central Norte PEMEX, MExico city, Mexico
⁹Hospital Israelita Albert Einstein, São Paulo, Brazil
¹⁰Hospital Del Salvador, Santiago, Chile
¹¹Instituto Alexander fleming, Buenos aires, Argentina
¹²Hospital Nacional Edgardo Rebagliati Martins, Lima, Peru
¹³Hospital De Clinicas, Montevideo, URY
¹⁴Hospital Nacional Edgardo Rebagliati Martins. Lima Peru, lima, Peru
¹⁵TEC Monterrey, Monterrey, TX, MEX
¹⁶Servicio de Hematología, Hospital Universitario "Dr. Jose Eleuterio Gonzalez", Universidad Autónoma de Nuevo León, Monterrey, NL, Mexico
¹⁷Servicio de Hematologia, Universidad Autonoma de Nuevo Leon, Hospital Universitario "Dr. José Eleuterio Gonzalez", Monterrey, Mexico
¹⁸Clinica Ruiz. Puebla, Puebla, Mexico
¹⁹Hospital de Alta Especialidad de Sonora, Sonora, Mexico
²⁰Dana-Farber Cancer Institute, Bing Center for Waldenström Macroglobulinemia, Boston, MA
²¹Department of Lymphoma and Myeloma, University of Texas MD Anderson cancer Center, Houston, TX

Christopher Grant, MD^1*, Danielle Brazel, MD² and Lauren C. Pinter-Brown^3*

¹Medicine, University of California, Irvine Medical Center, Orange, CA
²Scripps, La Jolla
³Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange, CA

Aditi Saha, MBBS¹, Junmin Whiting^2*, Mohammad Ammad-ud-din, MD^1*, Cole Powell^3*, Kristen Flores, BA^3*, Felix Sanjay^3*, Humaira Sarfraz, MBBS¹, Khushali Jhaveri, MD, MBBS¹, Michael V. Jaglal, MD¹, Katherine Tobon, PharmD^4*, Hayder Saeed, MD⁵, Celeste M. Bello, MD⁵, Bijal D. Shah, MD⁵, Leidy Lismeris Isenalumhe, MD, MS⁶, Javier Pinilla-Ibarz, MD, PhD⁵, Lubomir Sokol, MD, PhD⁵, Julio C Chavez, MD⁵ and Ning Dong, MD^5*

¹Department of Hematology/Oncology, Moffitt Cancer Center, Tampa, FL
²Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, FL
³University of South Florida Morsani College of Medicine, Tampa, FL
⁴Department of Pharmacy, Moffitt Cancer Center, Tampa, FL
⁵Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
⁶Moffitt Cancer Center, Tampa, FL

Karan Kanhai, MD, PhD¹, Sarah Littler, MSc^2*, Lynsey McColl, PhD^3*, Lisa Grant, PhD^4* and Christian Hoffmann, MD, PhD^5,6*

¹Recordati, Hemel Hempstead, United Kingdom
²Select Statistical Services, Exeter, United Kingdom
³Select Statistics, Exeter, United Kingdom
⁴TVF Communications, London, United Kingdom
⁵ICH Study Center, Hamburg, Germany
⁶University of Schleswig-Holstein, Kiel, Germany

Elise A. Chong, MD¹, Elicia Penuel, PhD², Nancy L. Bartlett, MD³, Francesc Bosch, MD, PhD⁴, Elizabeth Lihua Elizabeth Budde, MD, PhD⁵, Keith Fay, MBChB, FRACP, FRCPA^6*, Ian W. Flinn, MD, PhD⁷, Andre Goy, MD⁸, Anita Kumar, MD⁹, Rachel Lundberg, PA-C^1*, Ellen B. Napier, CRNP^1*, Loretta J. Nastoupil, MD¹⁰, Mazyar Shadman, MD¹¹, Michael C. Wei, MD, PhD², Mei Wu, PharmD^2*, Shen Yin, PhD^2*, Emeline R. Chong^1* and Stephen J. Schuster, MD¹

¹Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
²Genentech, Inc., South San Francisco, CA
³Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO
⁴Department of Hematology, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Barcelona, Spain
⁵Department of Hematology and HCT, City of Hope, Duarte, CA
⁶St Vincent's Hospital and Royal North Shore Hospital, Sydney, Australia
⁷Sarah Cannon Transplant and Cellular Therapy Program at TriStar Centennial Medical Center, Nashville, TN
⁸Lymphoma Division, John Theurer Cancer Center, Hackensack Meridian Health, Hackensack, NJ
⁹Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Short Hills, NJ
¹⁰MD Anderson Cancer Center, Houston, TX
¹¹Fred Hutchinson Cancer Research Center Seattle, Seattle, WA

Anne Akullo, MD^1,2*, Ruth Namazzi, MD^3,4,5*, Peter Wasswa, MD, MRCPCH, FRCPath^1*, Casey Lee McAtee, MD, MPH⁶, Moureen Nanvuma^3*, Hellen Alamo^7*, Hellen Mugarra Kabawheza, BSN, MPH^8*, Joseph Lubega, MD^6* and Carl E Allen, MD⁶

¹Pediatrics, Global Hematology Oncology Pediatric Excellence, Mulago Hospital, Kampala, Uganda
²Department of Pediatrics, Mulago National Referral Hospital, Kampala, Uganda
³Makerere University College of Health Sciences, Kampala, Uganda
⁴Department of Paediatrics, Makerere University, Kampala, Uganda
⁵Global Health Uganda, Kampala, Uganda
⁶Baylor College of Medicine, Houston, TX
⁷2Global Hematology Oncology Pediatric Excellence, Mulago Hospital, Kampala, Uganda
⁸Global Hematology Oncology Pediatric Excellence, Mulago Hospital, Kampala, Uganda

Sung-Soo Yoon, MD, PhD¹, Zhiming Li^2*, Keshu Zhou, MD^3*, Xiaoxi Zhou, MD^4*, Ye Guo, MD^5*, Huilai Zhang, MD^6*, Ki-Seong Eom^7*, Seok Jin Kim, MD, PhD⁸, Sung Yong Oh, MD^9*, Sung-Nam Lim, MD^10*, Hagop Youssoufian, MD^11*, Vernon Jiang, PhD^12*, Zhanchun Huang^11*, Georgina Kilfoil^11*, Xin Wang^11*, Zhixiang Cao^11*, Xiang LI^13*, Yihai Lin^11*, Alexander Wu, Ph.D.^11*, Yiyou Chen, Ph.D.^11* and Yuqin Song, MD¹⁴

¹Seoul National University Hospital, Seoul, South Korea
²Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China
³Department of Hematology, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China
⁴Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
⁵State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences&Peking Union Medical College, Tianjin, China
⁶Tianjin Medical Univ. Cancer Institute & Hospital, CHN, Tianjin, CHN
⁷Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
⁸Samsung Med. Ctr., Seoul, Korea, Republic of (South)
⁹Dong-A University Hospital, Busan, Korea, Republic of (South)
¹⁰Department of Hematology-Oncology, Inje University Haeundae Paik Hospital, Busan, Korea, Republic of (South)
¹¹Cothera Bioscience, San Mateo,, CA
¹²Cothera Bioscience, San Mateo, CA
¹³Cothera Bioscience, BEIJING, China
¹⁴Department of Lymphoma, Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, BEIJING, China

Philip A Haddad, MD¹, Jaren Lerner, MD^2* and Supriya Gupta, MD^3*

¹Feist-Weiller Cancer Center, LSUHSC-S/Overton Brooks VAMC, Shreveport, LA
²LSUHSC-S/Feist-Weiller Cancer Center, Shreveport
³LSUHSC-S/Feist-Weiller Cancer Center, Shreveport, LA

Kadhim Al-Banaa¹, Alfarooq Alshaikhli^2*, Shyam Poudel^1*, Shiva Shrotria^1*, Can Wang³, Paul Hanona^1*, Swathi Gopishetty¹, Precious Idogun, MD^4*, Daniel Ezekwudo, MD, PhD⁵ and Ishmael Jaiyesimi, DO⁵

¹Corewell Health William Beaumont University Hospital, Royal Oak, MI
²Detroit medical center, detroit, MI
³Corewell health William Beaumont University Hospital, Royal Oak, MI
⁴Hematology-Oncology, Beaumont Hospital, Royal Oak, MI
⁵Corewell Health William Beaumont University Hospital, Royal Oak

Luis Mario Villela Martinez, MD, MSc^1*, Brady E Beltran, MD^2*, Myrna Candelaria, MD, PharmD³, Marialejandra Torres Viera, MD^4*, Ana Florencia Ramirez, MD^5*, Henry Idrobo Quintero^6,7*, Carolina Oliver, MD^8,9, Guilherme Fleury Perini, MD¹⁰, Efreen H Montano Figueroa, MD^11*, Laura Korin, MD^12*, Lorena Fiad, MD^13*, German R. Stemmelin, MD^14*, Fernando Perez-Jacobo, MD^15*, Denisse Castro, MD¹⁶, Sally Rose Paredes, MD^17*, Victoria Irigoín, MD^18*, Perla R. Colunga-Pedraza, MD¹⁹, David Gomez-Almaguer, MD²⁰, Guillermo Ruiz-Argüelles, MD^21*, Fabiola Valvert, MD, FRCP²², Melani Otañez^23*, Arianna Robles Rodriguez^24*, Carlos Best^25*, Jose A Hernandez-Hernandez, PhD^26*, Luis Malpica, MD^27* and Jorge J. Castillo, MD²⁸

¹Centro Medico Dr. Ignacio Chavez, Hermosillo, Sonora, MEX
²Servicio Oncología Médica, Hospital Edgardo Rebagliati, Lima, Peru
³Clinical Research, Instituto Nacional de Cancerología, Mexico, Mexico
⁴Unidad Linfomas, Instituto Hematología y Oncología Universidad Central Venezuela, Caracas, Venezuela (Bolivarian Republic of)
⁵Instituto Nacional de Cancerologia, MExico city, Mexico
⁶Universidad del Valle, Cali, Colombia
⁷Clinica la Estancia, Popayan, Colombia
⁸CASMU, Montevideo, Uruguay
⁹British Hospital, Montevideo, Uruguay
¹⁰Hospital Israelita Albert Einstein, São Paulo, Brazil
¹¹Hospital General de Mexico, Mexico City, MEX
¹²CABA- Alexander Fleming Institute, Olivos, Argentina
¹³Italian Hospital, La Plata, Argentina
¹⁴Hospital Britanico BS.AS, Buenos Aires, Caba, ARG
¹⁵Hospital Central Norte Pemex, Ciudad de Mexico, Mexico
¹⁶Hospital Nacional Edgardo Rebagliati Martins, Lima, Peru
¹⁷Hospital Nacional Edgardo Rebagliati Martins. Lima Peru, lima, Peru
¹⁸Hospital De Clinicas, Montevideo, URY
¹⁹Servicio de Hematología, Hospital Universitario "Dr. Jose Eleuterio Gonzalez", Universidad Autónoma de Nuevo León, Monterrey, NL, Mexico
²⁰Servicio de Hematologia, Universidad Autonoma de Nuevo Leon, Hospital Universitario "Dr. José Eleuterio Gonzalez", Monterrey, Mexico
²¹Clinica Ruiz. Puebla, Puebla, Mexico
²²ICAN, Ciudad DE Guatemala, Guatemala
²³Hospital de Alta Especialidad de Sonora, Sonora, Mexico
²⁴Hematology, Hospital General de Occidente, Cdmx, MEX
²⁵Universidad De Guadalajara, Guadalajara, AG, MEX
²⁶TEC Monterrey, Monterrey, TX, MEX
²⁷Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
²⁸Dana-Farber Cancer Institute, Bing Center for Waldenström Macroglobulinemia, Boston, MA

Shuna Yao^1*, Zhihua Yao, PhD^1*, Zheng Yan^2*, Haiying Wang^3*, Junfeng Chu^3*, Shuang Zhao^4*, Xinyang Zhao, PhD⁵ and Yanyan Liu^1*

¹Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China
²Department of Internal Medicine Affiliated Cancer Hospital of Zhengzhou Universi, Zhengzhou, China
³Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, CHN
⁴Pediatric Translational Medicine Institute, Department of Internal Medicine Affiliated Cancer Hospital of Zhengzhou Universi, Zhengzhou, China
⁵University of Alabama At Birmingham, Birmingham, AL

Gustav Cederquist, MD, PhD^1*, Kathryn Tringale, MD, MAS^1*, Carla Hajj, MD^1*, Harper Hubbeling, MD¹, Jennifer Ma, MD^1*, Alexandra Dreyfuss, MD, MSTR^1*, Beatrice Fregonese, MPH^1*, Gilles Salles, MD, PhD², Christian Grommes, MD^3*, Michael Scordo⁴, Lorenzo Falchi, MD², Joachim Yahalom, MD¹ and Brandon S. Imber, MD, MA¹

¹Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
²Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York
³Department of Neurology, Memorial Sloan Kettering Cancer, New York, NY
⁴Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

Yusuke Naoi, MD^1,2*, Ryota Chijimatsu, PhD^2*, Tomohiro Urata, MD^3*, Kazutaka Sunami, MD, PhD⁴, Toshi Imai, MD, PhD^5*, Yuichiro Nawa, MD, PhD^6*, Yasushi Hiramatsu, MD, PhD^7*, Kazuhiko Yamamoto, MD, PhD^8*, Soichiro Fujii, MD, PhD^9*, Isao Yoshida, MD, PhD^10*, Tomofumi Yano, MD, PhD^11*, Kazuhiro Ikeuchi, MD^3*, Hiroki Kobayashi, MD^12*, Katsuma Tani, MD^3*, Hiroyuki Murakami, MD^3*, Hideki Ujiie^13*, Yasuharu Sato, PhD^14*, Katsuyoshi Takata, MD, PhD^15*, Merrill Boyle, BSc^16*, Aixiang Jiang, MS^16*, Yoshinobu Maeda, MD, PhD³, David W. Scott, MBChB, PhD¹⁷ and Daisuke Ennishi, MD, PhD¹⁸

¹Department of Hematology, Oncology and Respiratory Medicine, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Okayama, Japan
²Center of Comprehensive Genomic Medicine, Okayama University Hospital, Okayama, Japan
³Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
⁴Department of Hematology, National Hospital Organization, Okayama Medical Center, Okayama, Japan
⁵Hematology and Blood Transfusion, Kochi Health Sciences Center, Kochi, Japan
⁶Division of Hematology, Ehime Prefectural Central Hospital, Matsuyama, Japan
⁷Division of Hematology and Oncology, Japanese Red Cross Society Himeji Hospital, Himeji, Japan
⁸Department of Hematology and Oncology, Okayama City Hospital, Okayama, Japan
⁹Department of Hematology, Japanese Red Cross Okayama Hospital, Okayama, Japan
¹⁰Department of Hematologic Oncology, National Hospital Organization Shikoku Cancer Center, Mastuyama, Japan
¹¹Department of Internal Medicine, Okayama Rosai Hospital, Okayama, Japan
¹²Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Kamogawa, CHI, Japan
¹³Department of Molecular Hematopathology, Okayama University Graduate School of Health Sciences, Okayama, Japan
¹⁴Department of Molecular Hematopathology, Okayama University, Okayama, Japan
¹⁵Division of Molecular and Cellular Pathology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan
¹⁶Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada
¹⁷Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada
¹⁸Okayama University Hospital, Okayama, Japan

Marie José Kersten, MD, PhD¹, Umar Farooq², Aaron P. Rapoport, MD³, Frederick L. Locke, MD⁴, Lori A. Leslie, MD⁵, Armin Ghobadi, MD⁶, David B. Miklos, MD, PhD⁷, Caron A Jacobson, MD, MMSc⁸, Javier L. Munoz⁹, Patrick B Johnston, MD, PhD^10*, Samantha M. Jaglowski, MD, MPH¹¹, Ian W. Flinn, MD, PhD¹², Tom van Meerten, MD, PhD^13*, Miguel-Angel Perales, MD¹⁴, Peter Vandenberghe, MD, PhD¹⁵, Peter A. Riedell, MD¹⁶, Kathleen Dorritie, MD¹⁷, David Szwajcer, MD^18*, Dimitrios Tzachanis, MD, PhD¹⁹, Saran Vardhanabhuti^20*, Linqiu Du^20*, Simone Filosto^20*, Shilpa A. Shahani, MD^20*, Christina To, MD²¹ and Jason Westin, MD²²

¹Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands
²Holden Comprehensive Cancer Center, University of Iowa Hospital and Clinics, Iowa City, IA
³University of Maryland, Baltimore, MD
⁴H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁵Lymphoma Division, John Theurer Cancer Center, Hackensack Meridian School of Medicine, Hackensack, NJ
⁶Division of Oncology, Washington University School of Medicine, Saint Louis, MO
⁷Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University, Palo Alto, CA
⁸Dana-Farber Cancer Institute, Boston, MA
⁹Banner MD Anderson Cancer Center, Phoenix, AZ
¹⁰Division of Hematology, Mayo Clinic, Rochester, MN
¹¹Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
¹²Sarah Cannon Research Institute, Nashville, TN
¹³University Medical Center Groningen,, Groningen, Netherlands
¹⁴Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
¹⁵Department of Hematology, Department of Human Genetics, University Hospitals Leuven, KU Leuven, Leuven, Belgium
¹⁶David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL
¹⁷UPMC Hillman Cancer Center, Pittsburgh, PA
¹⁸Department of Internal Medicine, University of Manitoba, Winnipeg, Canada
¹⁹Moores Cancer Center, University of California San Diego, Carlsbad, CA
²⁰Kite, a Gilead Company, Santa Monica, CA
²¹Kite Pharma, a Gilead company, Santa Monica, CA
²²Department of Lymphoma and Myeloma, The University of Texas M D Anderson Cancer Center, Houston, TX

Yuma Nato, MD^1*, Kana Miyazaki, MD, PhD², Dai Maruyama³, Hiroyuki Takahashi, MD, PhD⁴, Kazutaka Sunami, MD, PhD⁵, Satsuki Murakami, MD, PhD^6*, Eiju Negoro, MD, PhD^7*, Yuri Miyazawa, MD, PhD^8*, Ilseung Choi, MD, PhD⁹, Takahiro Okada, MD, PhD^10*, Nobuyuki Takayama, MD, PhD¹¹, Naoto Tomita, MD, PhD¹², Shuji Momose, MD, PhD^13*, Yuto Kaneda, MD, PhD^14*, Masahiro Yoshida, MD, PhD^15*, Hiroshi Gomyo, MD, PhD^16*, Kohtaro Toyama, MD, PhD^17*, Momoko Nishikori, MD, PhD¹⁸, Akio Saito, MD, PhD^19*, Junji Hiraga, MD, PhD^20*, Taro Masunari, MD^21*, Naoki Takahashi, MD, PhD^22*, Junya Makiyama, MD, PhD²³, Tomotaka Suzuki^24*, Hiroko Tsunemine, MD, PhD^25*, Jun Takizawa, MD, PhD^26*, Takeharu Kato, MD, PhD^27*, Yasufumi Masaki, MD, PhD²⁸, Noriko Fukuhara²⁹, Masataka Okamoto, MD, PhD^30*, Isao Tawara, MD, PhD², Naoko Asano, MD, PhD³¹, Koichi Ohshima, MD, PhD^32*, Koji Izutsu, MD, PhD³³, Koji Kato, MD, PhD³⁴, Ritsuro Suzuki, MD, PhD¹⁰ and Motoko Yamaguchi, MD, PhD¹

¹Department of Hematological Malignancies, Mie University Graduate School of Medicine, Tsu, Japan
²Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, Japan
³Department of Hematology Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
⁴Department of Pediatrics, Toho University, Tokyo, Japan
⁵Department of Hematology, National Hospital Organization, Okayama Medical Center, Okayama, Japan
⁶Department of Hematology, Aichi Medical University School of Medicine, Nagakute, Japan
⁷Department of Hematology and Oncology, University of Fukui, Fukui, Japan
⁸Department of Hematology, Gunma University Graduate School of Medicine, Maebashi, Japan
⁹Department of Hematology and cell therapy, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
¹⁰Department of Hematology and Oncology, Shimane University School of Medicine, Izumo, Japan
¹¹Department of Hematology, Kyorin University Faculty of Medicine, Mitaka, Japan
¹²Department of Hematology and Oncology, St. Marianna University School of Medicine, Kawasaki, Japan
¹³Department of Pathology, Saitama Medical Center, Saitama Medical University, Saitama, Japan
¹⁴Department of Hematology and Infectious Disease, Gifu University Hospital, Gifu, Japan
¹⁵Department of Hematology, Osaka City General Hospital, Osaka, Japan
¹⁶Department of Hematology, Hyogo Cancer Center, Akashi, Japan
¹⁷Department of Hematology, Fujioka General Hospital, Fujioka, Japan
¹⁸Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
¹⁹Department of Hematology, National Hospital Organization Shibukawa Medical Center, Gunma, Japan
²⁰Department of Hematology, Toyota Memorial Hospital, Toyota, Japan
²¹Department of Hematology/Infectious Diseases, Chugoku Central Hospital, Fukuyama, Japan
²²Department of Hematology, International Medical Center, Saitama Medical University, Saitama, Japan
²³Department of Hematology, Sasebo City General Hospital, Sasebo, Japan
²⁴Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
²⁵Department of Hematology, Shinko Hospital, Kobe, Japan
²⁶Department of Hematology, Endocrinology and Metabolism, Niigata University Faculty of Medicine, Niigata, Japan
²⁷Department of Hematology, Nagasaki University Hospital, Nagasaki, Japan
²⁸Department of Hematology and Immunology, Kanazawa Medical University, Kahoku-Gun, Japan
²⁹Department of Hematology, Tohoku University Hospital, Sendai, Japan
³⁰Department of Hematology and Oncology, Fujita Health University Okazaki Medical Center, Okazaki, Japan
³¹Department of Molecular Diagnostics, Nagano Prefectural Shinshu Medical Center, Suzaka, Japan
³²Department of Pathology, Kurume University School of Medicine, Kurume, Japan
³³Department of Hematology, National Cancer Center Hospital, Tokyo, Japan
³⁴Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan

Hao-Yuan Wang, MD¹, Fu-Chen Yang, PhD^2*, Ching-Fen Yang, MD^3*, Chun-Kuang Tsai, MD^1*, Po-Shen Ko, MD^1*, Yao-Chung Liu, MD^1* and Nien-Jung Chen, PhD^2*

¹Division of Hematology and Oncology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan
²Institute of Microbiology and Immunology, National Yang Ming Chiao Tung University, Taipei, Taiwan
³Department of Pathology and Laboratory Medicine, Taipei Veterans General Hospital, Taipei, Taiwan

Gabriel Antherieu, PhD^1*, Edith Julia^1*, Alizee Maarek, MD^1*, Violaine Safar, MD^1*, Emmanuelle Ferrant, MD^1*, Alexandra Traverse-Glehen, MD, PhD^2*, Anne Lazareth, MD^1*, Helene Lequeu, MD^1*, Stéphanie Cordeil, PhD, MD^1*, Guillaume Aussedat, MD^1*, Camille Golfier, MD^1*, Dana Ghergus, MD^1*, Pierre Sesques^3*, Lionel Karlin^1*, Fadhela Bouafia Sauvy, MD^1*, Gilles Salles, MD, PhD¹, Emmanuel Bachy, MD, PhD^4*, Emmanuel Jouanneau, MD, PhD^5*, Francois Ducray, MD, PhD^6*, Loic Boussel, MD, PhD^7* and Herve Ghesquieres, MD^1*

¹Department of Hematology, Lyon Sud Hospital, Pierre Benite, France
²Department of Pathology, Lyon Sud Hospital, Pierre Benite, France
³Lyon Sud Hospital, Lyon, France
⁴Hematology Department, Lyon Sud Hospital, Pierre-Bénite, France
⁵Department of Neurosurgery, Neurology Hospital, Bron, France
⁶Department of Neurology, Neurology Hospital, Bron, France
⁷Department of Radiology, Croix Rousse Hospital, Lyon, France

Abdul Rahman Al Armashi, MD^1*, Anas Al Zubaidi, MD^2*, Omar Mahmood³, Marisa Thierheimer^4*, Akram Alkrekshi, MD^5* and Haifaa Abdulhaq, MD⁶

¹Seidman Cancer Center/Case Western Reserve University/Case Comprehensive Cancer Center, Cleveland, OH
²Johns Hopkins University - School of Medicine, Baltimore, MD
³Hematology/Oncology, University of California San Francisco-Fresno, FRESNO, CA
⁴School of Medicine, Case Western Reserve University, Cleveland, OH
⁵MetroHealth/Case Western Reserve University, Clevalnd, OH
⁶University of California San Francisco-Fresno, Fresno, CA

Paolo F. Caimi, MD¹, Christine Auberle, MD², Krishna Goparaju, MD^3*, Molly Megan Gallogly, MD, PhD⁴, Firas Baidoun, MD^5*, Amanda F Cashen⁶ and Brian T. Hill, MD⁷

¹Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
²Washington University School of Medicine, St. Louis, MO
³Case Western Reserve University, Cleveland, OH
⁴University Hospitals Seidman Cancer Center, Cleveland, OH
⁵Cleveland Clinic Taussig Cancer Center, Cleveland, OH
⁶Washington Univ. School of Med., Saint Louis, MO
⁷Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH

Robert Sgrignoli, DO¹, Matthew Joseph Rendo, MD^2*, Kevin Sunderland, PhD^3*, Joshua Fenderson, MD^4*, Chungting Kou, MD^5*, James K Aden, PhD^5*, Michael J Morris, MD^5* and Christin DeStefano, MD⁶

¹Walter Reed National Military Medical Center, Bethesda, MD
²Wright Patterson Air Force Base, Dayton, OH
³David Grant USAF Medical Center, Fairfield, CA
⁴Brooke Army Medical Center, San Antonio, TX
⁵Brooke Army Medical Center, San Antonio
⁶Walter Reed National Military Medical Center, Chevy Chase, MD

Richard C. Godby, MD¹, Steven R. Hwang, MD¹, Brianna Gysbers^1*, Raphael Mwangi, M.S.^1*, Matthew J. Maurer, DrMed^2*, Thomas E. Witzig, MD¹, Jonas Paludo, MD¹, J. C. Villasboas, MD^1*, Urshila Durani, MD, MPH¹, Thomas M. Habermann, MD¹, Grzegorz S. Nowakowski, MD³, Arushi Khurana, MBBS⁴ and Patrick B Johnston, MD, PhD^4*

¹Mayo Clinic, Rochester, MN
²Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
³Department of Internal Medicine, Mayo Clinic, Rochester, MN
⁴Mayo Clinic, Co-Senior Author, Rochester, MN

Xiaoya Yun^1*, Jiefei Bai^1*, Ru Feng^1*, Jiangtao Li, PhD^1*, Ting Wang^1*, Yazi Yang^1*, Jingjing Yin^1*, Long Qian^1*, Shuai Zhang^1*, Qingyun Cao^1*, Xiaoxuan Xue^1*, Hongmei Jing² and Hui Liu^1*

¹Beijing Hospital, Beijing, China
²Peking University Third Hospital, Beijing, CHN

Victor Ramon Mendiola, MD¹, Sergio A. Vallejo, MD^2*, Qianqian Liu, PhD^3*, Joel Michalek, PhD^3* and Adolfo Diaz Duque, MD, MSc⁴

¹Mays Cancer Center, University of Texas Health Sciences Center of San Antonio, SAN ANTONIO, TX
²UTHSCSA, San Antonio, TX
³Department of Population Health Sciences, University of Texas Health-San Antonio, San Antonio, TX
⁴Department of Medicine Division of Hematology-Oncology, University of Texas Health-San Antonio, San Antonio, TX

Anna Ruckdeschel, MD^1*, Koemm Sabrina^1*, Max S. Topp, MD^1*, Richard Greil, MD², Thomas Melchardt, MD^2*, Georg Lenz³, Andrea Kerkhoff, MD^4*, Evgenii Shumilov, MD^4*, Georg Hess^5*, Marta Baumgaertner^5*, Lorenz Thurner, MD⁶, Igor Age Kos^7*, Stephanie Mayer^8*, Francis A. Ayuk, MD^9*, Rolf Krause^9*, Marco Herling^10*, Vladan Vucinic, M.D.^11*, Claudia Chapuy^12*, Gerald Illerhaus, MD¹³, Markus Knott, MD^13*, Andreas Viardot, MD PhD¹⁴, Alexander Grunenberg^14*, Sascha Dietrich, MD^15*, Leandra Caille^15*, Mareike C. Tometten^16*, Hyunyee Rosa Cho^16*, Julia Scholz^17*, Fabian Mueller, MD^17*, Katharina Prochazka^18*, Bjoern Chapuy, MD¹⁹, David Böckle^19*, Bastian von Tresckow, MD²⁰, Natalie Schub^21*, Götz Gelbrich^22*, Hermann Einsele, MD, PhD^23* and Johannes Duell, MD^1*

¹Department of Internal Medicine II, Hematology and Oncology, University Hospital Wuerzburg, Wuerzburg, Germany
²Paracelsus Medical University, Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute - Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Salzburg, Austria
³Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, Muenster, Germany
⁴Medical Department A for Hematology, Oncology, and Pneumology, University Hospital Muenster, Muenster, Germany
⁵University Clinic Mainz, Mainz, Germany
⁶Department of Internal Medicine 1, Oncology, Hematology, Clinical Immunology, and Rheumatology, Saarland University Medical Center, Homburg/Saar, Germany
⁷Department of Internal Medicine 1, Oncology, Hematology, Clinical Immunology, and Rheumatology, Saarland University Medical Center, Homburg, Germany
⁸Universitätsklinikum Regensburg, Regensburg, DEU
⁹Department of Stem Cell Transplantation with Research Department Cell and Gene Therapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
¹⁰Department of Hematology, Cellular Therapy, Hemostaseology and Infectious Diseases, University Leipzig Medical Center, Leipzig, Germany
¹¹Department of Hematology, Cellular Therapy, Hemostaseology and Infectious Diseases, University of Leipzig, Leipzig, Germany
¹²University Medical Center Göttingen, Georg-August-Universität Göttingen, Göttingen, Germany
¹³Department of Hematology/Oncology and Palliative Care, Klinikum Stuttgart, Stuttgart, Germany
¹⁴Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany
¹⁵Heidelberg University Hospital, Heidelberg, DEU
¹⁶RWTH Aachen University, Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty, Aachen, Germany
¹⁷Department of Internal Medicine 5, Hematology and Oncology, University Hospital of Erlangen, Erlangen, Germany
¹⁸Medical University of Graz, Graz, AUT
¹⁹Department of Hematology, Oncology and Tumor Immunology, Charité - University Medical Center Berlin, Campus Benjamin Franklin, Berlin, Germany
²⁰Department of Hematology and Stem Cell Transplantation, West German Cancer Center Essen, Essen, Germany
²¹University Hospital Schleswig-Holstein, Campus Kiel, Division For Stem Cell Transplantation and Immunotherapy, 2nd Department of Medicine, Kiel, Germany
²²Institute of Clinical Epidemiology and Biometry, University of Wuerzburg, Würzburg, DEU
²³Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany

Jun Ho Yi, MD¹, Seok Jin Kim, MD, PhD², Sang A Kim, MD^3*, Jongheon Jung, MD^4* and Dok Hyun Yoon, MD, PhD^5*

¹Chung-Ang University, Seoul, South Korea
²Samsung Med. Ctr., Seoul, Korea, Republic of (South)
³Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University, Seongnam, Korea, Republic of (South)
⁴Center for hematologic malignancies, Goyang-Si, Gyunggi-Do, Korea, Republic of (South)
⁵Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)

Tatyana Feldman, MD¹, Alexandra Della Pia, PharmD^2*, Geeny Lee, PharmD^3*, Thomas S. Gunning, BS⁴, Michael Pelliccia^5*, Tony Varughese, MD³, Harsh Parmar, MBBS⁶, Andrew Ip, MD, MSc¹, Lori A. Leslie, MD⁷, Andre Goy, MD¹ and Samuel Singer, MD^8*

¹Lymphoma Division, John Theurer Cancer Center, Hackensack Meridian Health, Hackensack, NJ
²John Theurer Cancer Center, Towaco, NJ
³Hackensack University Medical Center, Hackensack, NJ
⁴Hackensack Meridian School of Medicine, Clifton, NJ
⁵Hackensack Meridian School of Medicine, Nutley, NJ
⁶Multiple Myeloma Division, John Theurer Cancer Center, Hackensack Meridian Health, Hackensack, NJ
⁷Lymphoma Division, John Theurer Cancer Center, Hackensack Meridian School of Medicine, Hackensack, NJ
⁸Northwell Health, New Hyde Park, NY

Heidi Latiolais, MD, MSc¹, Qianqian Liu, PhD^2*, Joel Michalek, PhD^2* and Adolfo Enrique Diaz Duque, MD³

¹University of Texas Health Science Center at San Antonio, San Antonio, TX
²Department of Population Health Sciences, University of Texas Health-San Antonio, San Antonio, TX
³MD Anderson, University of Texas San Antonio, San Antonio, TX

Luis Mario Villela Martinez, MD, MSc^1*, Brady E Beltran, MD^2*, Myrna Candelaria, MD, PharmD³, Ana Florencia Ramirez, MD^4*, Marialejandra Torres Viera, MD^5*, Carolina Oliver, MD^6,7, Henry Idrobo Quintero^8,9*, Fernando perez-Jacobo, MD^10*, Arianna Robles Rodriguez^11*, Guilherme F Perini, MD^12*, Camila Peña, MD¹³, Laura Korin, MD^14*, Denisse Castro, MD¹⁵, Victoria Irigoín, MD^16*, Sally Rose Paredes, MD^17*, Jose A Hernandez-Hernandez, PhD^18*, Perla R. Colunga-Pedraza, MD¹⁹, David Gomez-Almaguer, MD²⁰, Guillermo Ruiz-Argüelles, MD^21*, Melani Otañez^22*, Rosa Oliday Rios Jiménez^23*, Carlos Gil Rondero^24*, Jorge J. Castillo, MD²⁵, Fabiola Valvert, MD, FRCP²⁶ and Luis Malpica, MD^27*

¹Hospital Fernando Ocaranza., Hermosillo, Sonora, Mexico
²Servicio Oncología Médica, Hospital Edgardo Rebagliati, Lima, Peru
³Clinical Research, Instituto Nacional de Cancerología, Mexico, Mexico
⁴Instituto Nacional de Cancerologia, MExico city, Mexico
⁵Unidad Linfomas, Instituto Hematología y Oncología Universidad Central Venezuela, Caracas, Venezuela (Bolivarian Republic of)
⁶CASMU, Montevideo, Uruguay
⁷British Hospital, Montevideo, Uruguay
⁸Universidad del Valle, Cali, Colombia
⁹Clinica la Estancia, Popayan, Colombia
¹⁰Hospital Central Norte PEMEX, MExico city, Mexico
¹¹Hematology, Hospital General de Occidente, Cdmx, MEX
¹²Hospital Israelita Albert Einstein, Sao Paulo, Brazil
¹³Hospital Del Salvador, Santiago, Chile
¹⁴CABA- Alexander Fleming Institute, Olivos, Argentina
¹⁵Hospital Nacional Edgardo Rebagliati Martins, Lima, Peru
¹⁶Hospital De Clinicas, Montevideo, URY
¹⁷Hospital Nacional Edgardo Rebagliati Martins. Lima Peru, lima, Peru
¹⁸TEC Monterrey, Monterrey, TX, MEX
¹⁹Servicio de Hematología, Hospital Universitario "Dr. Jose Eleuterio Gonzalez", Universidad Autónoma de Nuevo León, Monterrey, NL, Mexico
²⁰Servicio de Hematologia, Universidad Autonoma de Nuevo Leon, Hospital Universitario "Dr. José Eleuterio Gonzalez", Monterrey, Mexico
²¹Clinica Ruiz. Puebla, Puebla, Mexico
²²Hospital de Alta Especialidad de Sonora, Sonora, Mexico
²³Hospital Clínico Quirúrgico Hermanos Amejeiras, La Habana, Cuba
²⁴Hospital Fernando Ocaranza, Hermosillo, BCN, MEX
²⁵Dana-Farber Cancer Institute, Bing Center for Waldenström Macroglobulinemia, Boston, MA
²⁶ICAN, Ciudad DE Guatemala, Guatemala
²⁷Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX

Aditi Saha, MBBS¹, Razan Mohty, MD², Junmin Whiting^3*, Kristen Flores, BA^4*, Jongphil Kim, PhD^3*, Taiga Nishihori, MD², Julio C Chavez, MD⁵, Farhad Khimani, MBBS^2*, Doris K. Hansen, MD², Fabiana Perna, MD, PhD², Hien Liu, MD⁶, Bijal D. Shah, MD⁵, Marian Dam^2*, Muhammad Jaffer, MD^7*, Sepideh Mokhtari, MD^7*, Hany Elmariah, MD, MS², Rawan Faramand, MD², Christina A Bachmeier, PharmD^2*, Nelli Bejanyan, MD^2*, Frederick L. Locke, MD², Michael D. Jain, MD, PhD² and Aleksandr Lazaryan, MD, MPH, PhD²

¹Department of Hematology/Oncology, Moffitt Cancer Center, Tampa, FL
²Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
³Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, FL
⁴University of South Florida Morsani College of Medicine, Tampa, FL
⁵Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
⁶Moffitt Cancer Center, Tampa, FL
⁷Department of Neuro-Oncology, Moffitt Cancer Center, Tampa, FL